These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 34546409)
1. Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation. Hiramoto N; Yamazaki H; Nakamura Y; Uchida N; Murata M; Kondo T; Yoshioka S; Eto T; Nishikawa A; Kimura T; Ichinohe T; Atsuta Y; Onishi Y; Suzuki R; Mori T; Ann Hematol; 2022 Jan; 101(1):165-175. PubMed ID: 34546409 [TBL] [Abstract][Full Text] [Related]
2. Umbilical Cord Blood Transplantation Using Reduced-Intensity Conditioning without Antithymocyte Globulin in Adult Patients with Severe Aplastic Anemia. Ochi T; Onishi Y; Nasu K; Onodera K; Kobayashi M; Ichikawa S; Fujiwara T; Fukuhara N; Yamada-Fujiwara M; Harigae H Biol Blood Marrow Transplant; 2019 Feb; 25(2):e55-e59. PubMed ID: 30292011 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG. Kim H; Lee KH; Kim I; Sohn SK; Jung CW; Joo YD; Kim SH; Kim BS; Choi JH; Kwak JY; Kim MK; Bae SH; Shin HJ; Won JH; Lee WS; Oh S; Kim HJ; Park JH; Leuk Res; 2014 Jul; 38(7):730-6. PubMed ID: 24840870 [TBL] [Abstract][Full Text] [Related]
4. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan. Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274 [TBL] [Abstract][Full Text] [Related]
5. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Deeg HJ; Amylon ID; Harris RE; Collins R; Beatty PG; Feig S; Ramsay N; Territo M; Khan SP; Pamphilon D; Leis JF; Burdach S; Anasetti C; Hackman R; Storer B; Mueller B Biol Blood Marrow Transplant; 2001; 7(4):208-15. PubMed ID: 11349807 [TBL] [Abstract][Full Text] [Related]
7. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies]. Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651 [TBL] [Abstract][Full Text] [Related]
8. Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study. Peffault de Latour R; Chevret S; Jubert C; Sirvent A; Galambrun C; Ruggeri A; Gandemer V; Cornillon J; Rialland F; Dalle JH; Forcade E; Bruno B; Paillard C; Rorlich PS; Salmon A; Fürst S; Sicre de Fontbrune F; Rubio MT; Bay JO; Mohty M; Larghero J; Gluckman E; Socié G; Blood; 2018 Aug; 132(7):750-754. PubMed ID: 29760162 [TBL] [Abstract][Full Text] [Related]
9. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate. Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856 [TBL] [Abstract][Full Text] [Related]
10. An Antithymocyte Globulin-Free Conditioning Regimen Using Fludarabine and Cyclophosphamide Is Associated with Good Outcomes in Patients Undergoing Matched Related Family Donor Transplantation for Aplastic Anemia. George B; Lionel S; Selvarajan S; Abubacker FN; Korula A; Devasia AJ; Kulkarni U; Lakshmi KM; Sindhuvi E; Abraham A; Mathews V Transplant Cell Ther; 2021 May; 27(5):409.e1-409.e6. PubMed ID: 33965181 [TBL] [Abstract][Full Text] [Related]
11. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Bacigalupo A; Socie' G; Lanino E; Prete A; Locatelli F; Locasciulli A; Cesaro S; Shimoni A; Marsh J; Brune M; Van Lint MT; Oneto R; Passweg J; Haematologica; 2010 Jun; 95(6):976-82. PubMed ID: 20494932 [TBL] [Abstract][Full Text] [Related]
12. [Reduced-intensity umbilical cord blood transplantation for adult patients with fulminant aplastic anemia]. Nishiwaki K; Sano K; Kamiyama Y; Hayashi K; Tanoue S; Katori M; Masuoka H; Aiba K Rinsho Ketsueki; 2018; 59(1):64-68. PubMed ID: 29415940 [TBL] [Abstract][Full Text] [Related]
13. [Single non-blood-related umbilical cord blood transplantation using a reduced-intensity conditioning regimen for the treatment of severe aplastic anemia]. Wu Y; Tang BL; Song KD; Sun GY; Pan TZ; Huang AJ; Yan BB; Zhu XY Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):68-73. PubMed ID: 38527841 [No Abstract] [Full Text] [Related]
14. Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia. Arcuri LJ; Nabhan SK; Cunha R; Nichele S; Ribeiro AAF; Fernandes JF; Daudt LE; Rodrigues ALM; Arrais-Rodrigues C; Seber A; Atta EH; de Oliveira JSR; Funke VAM; Loth G; Junior LGD; Paz A; Calixto RF; Gomes AA; Araujo CES; Colturato V; Simoes BP; Hamerschlak N; Flowers ME; Pasquini R; Rocha V; Bonfim C Biol Blood Marrow Transplant; 2020 Dec; 26(12):2311-2317. PubMed ID: 32949751 [TBL] [Abstract][Full Text] [Related]
15. A comparative study of porcine antihuman lymphocyte globulin versus antithymocyte globulin-fresenius in an allogeneic hematopoietic cell transplantation conditioning regimen for severe aplastic anemia. Zhang Y; Liu L; Si Y; Miao M; Qiu H; Tang X; Han Y; Fu C; Jin Z; Chen S; Sun A; Wu D Hematology; 2021 Dec; 26(1):741-750. PubMed ID: 34555301 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of Haploidentical Stem Cell Transplantation using Total Body Irradiation (600 cGy) and Fludarabine with Antithymocyte Globulin in Adult Patients with Severe Aplastic Anemia: A Prospective Phase II Study. Lee SE; Min GJ; Park SS; Park S; Yoon JH; Shin SH; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Lee JW Biol Blood Marrow Transplant; 2020 Oct; 26(10):1906-1914. PubMed ID: 32634577 [TBL] [Abstract][Full Text] [Related]
17. Outcome of first or second transplantation using unrelated umbilical cord blood without ATG conditioning regimen for pediatric bone marrow failure disorders. Chen X; Liu F; Ren Y; Zhang L; Wan Y; Yang W; Chen X; Zhang L; Zou Y; Chen Y; Zhu X; Guo Y Blood Cells Mol Dis; 2024 Jan; 104():102793. PubMed ID: 37659255 [TBL] [Abstract][Full Text] [Related]
18. Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children. Sawada A; Shimizu M; Koyama-Sato M; Higuchi K; Okada Y; Goto K; Inoue S; Yasui M; Inoue M Int J Hematol; 2022 Feb; 115(2):269-277. PubMed ID: 34739700 [TBL] [Abstract][Full Text] [Related]
19. Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia. Fu H; Xu L; Liu D; Liu K; Zhang X; Chen H; Chen Y; Han W; Wang Y; Wang J; Wang F; Huang X Biol Blood Marrow Transplant; 2014 Aug; 20(8):1176-82. PubMed ID: 24747336 [TBL] [Abstract][Full Text] [Related]
20. Comparisons of Modified Post-Transplantation Cyclophosphamide and Granulocyte Colony-Stimulating Factor/Antithymocyte Globulin Regimens for Haploidentical Stem Cell Transplantation in Patients with Aplastic Anemia. Li Y; Lu X; Wang N; Zhang X; Cao Y; Xiao Y; Meng F; Zhang D; You Y; Zou L; Cheng H; Guo J; Zhang Y; Huang Z; Yuan G; Wei J; Wang H; Xia L; Zhang Y Transplant Cell Ther; 2022 Jul; 28(7):396.e1-396.e9. PubMed ID: 35513253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]